Shares of Endava plc (NYSE:DAVA – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eleven ratings firms that are covering the company, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $39.10.
DAVA has been the topic of several recent research reports. Needham & Company LLC reduced their target price on shares of Endava from $43.00 to $38.00 and set a “buy” rating on the stock in a report on Friday, February 21st. Susquehanna reduced their price objective on Endava from $55.00 to $50.00 and set a “positive” rating on the stock in a research note on Friday, February 21st. Finally, Morgan Stanley upped their target price on Endava from $33.00 to $35.00 and gave the stock an “equal weight” rating in a research report on Friday, January 31st.
Get Our Latest Stock Report on DAVA
Endava Stock Performance
Endava (NYSE:DAVA – Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.18). Endava had a return on equity of 0.89% and a net margin of 0.74%. The business had revenue of $250.63 million for the quarter, compared to analyst estimates of $197.33 million. As a group, research analysts forecast that Endava will post 0.57 earnings per share for the current year.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Charles Schwab Investment Management Inc. raised its position in shares of Endava by 120.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 20,165 shares of the company’s stock valued at $515,000 after purchasing an additional 11,020 shares in the last quarter. HighTower Advisors LLC increased its stake in shares of Endava by 11.7% in the third quarter. HighTower Advisors LLC now owns 15,143 shares of the company’s stock worth $390,000 after buying an additional 1,592 shares during the last quarter. State Street Corp raised its holdings in Endava by 33.0% in the third quarter. State Street Corp now owns 80,148 shares of the company’s stock valued at $2,047,000 after acquiring an additional 19,884 shares in the last quarter. 272 Capital LP boosted its stake in Endava by 156.3% during the 3rd quarter. 272 Capital LP now owns 145,146 shares of the company’s stock valued at $3,707,000 after acquiring an additional 88,518 shares during the last quarter. Finally, GAMMA Investing LLC grew its holdings in Endava by 86.4% during the 4th quarter. GAMMA Investing LLC now owns 1,607 shares of the company’s stock worth $50,000 after acquiring an additional 745 shares in the last quarter. Hedge funds and other institutional investors own 62.23% of the company’s stock.
Endava Company Profile
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Featured Stories
- Five stocks we like better than Endava
- The Risks of Owning Bonds
- Can IBM’s Q1 Earnings Spark a Breakout for the Stock?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- S&P 500 and Nasdaq-100 Flashed Death Crosses—Should You Worry?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Fundamentally Sound, These 5 Stocks Sold Off Anyway
Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.